| Date | Company | Amount | Funding type | Investors | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2014-07-22 | Trianta Immunotherapies, a Medigene subsidiary (Germany) | grant | German Research Foundation (DFG) (Germany) | Cancer - Oncology | Grant | |
| 2014-07-21 | Celsion (USA - NJ) | $1 million | grant | National Institutes of Health\'s Center for Biomedical Imaging and Bioengineering (NIBIB) (USA) | Cancer - Oncology | Grant |
| 2014-07-17 | BioAlliance Pharma (France) | €10 million | loan | Financière de la Montagne (France) | Cancer - Oncology - Rare diseases | Loan |
| 2014-07-17 | Bone Therapeutics (Belgium) Image Analysis (UK) SIRRIS (Belgium) | €576,000 | grant | M-ERA.net | Bone diseases - Regenerative medicine | Grant |
| 2014-07-17 | Paion (Germany) | € 4 million | private placement | Pharmascience International, Pendopharm\'s affiliate (Canada) | Private placement | |
| 2014-07-16 | Immatics (Germany) | €34 million | Series D financing round | dievini Hopp Biotech (Germany), Wellington Partners (USA), MIG-advised funds, AT Impf GmbH (Germany) | Cancer - Oncology | Series D financing round |
| 2014-07-16 | Oncobiologics (USA - NJ) | undisclosed | Strides Arcolab (India) | Establishment of a new subsidiary in the EU | ||
| 2014-07-15 | amcure (Germany) | € 5 million | series A financing round and grant | LBBW Venture Capital (Germany), KfW (Germany), MBG Mittelstaendische Beteiligungsgesellschaft Baden-Wuerttemberg (Germany), S-Kap Beteiligungen Pforzheim (Germany), BioM AG (Germany), private investors, German Ministry of Education and Research (BMBF) (Germany) | Cancer - Oncology | Series A financing round |
| 2014-07-15 | Medigene (Germany) | € 15.9 million | capital increase | Cancer - Oncology | Capital increase | |
| 2014-07-09 | Domainex (UK) | £1.4 million (€1.76 million) | grant | Biomedical Catalyst Fund (UK) | Inflammatory diseases - Respiratory diseases | Grant |
| 2014-07-08 | Argen-X (Belgium - The Netherlands) | € 40 million | IPO | corporate and institutional investors in Europe and USA, Belgian retail investors, Shire (UK - USA) | Cancer - Oncology - Autoimmune diseases | IPO |
| 2014-07-08 | Biotie Therapies (Finland) | $2 million | grant | The Michael J. Fox Foundation - MJFF (USA) | Neurodegenerative diseases | Grant |
| 2014-07-08 | Sophia Genetics (Switzerland) | $13.75 million (€ 10.1 million) | series B financing round | Invoke Capital (UK - USA), Endeavour Vision (Switzerland), Swisscom (Switzerland) | Genetic diseases | Series B financing round |
| 2014-07-08 | Cynapsus Therapeutics (Canada) | $0.5 million | grant | The Michael J. Fox Foundation - MJFF (USA) | Neurodegenerative diseases | Grant |
| 2014-07-08 | Bluebird Bio (USA - MA) | $95.6 million | IPO | Rare diseases | IPO | |
| 2014-07-07 | Abzena (UK) | £20 million (€25.2 million) | IPO | Technology - Services | IPO | |
| 2014-07-04 | C4X Discovery (UK) | £1.48 million (€1.86 million) | grant | Biomedical Catalyst Fund (UK) | Metabolic diseases | Grant |
| 2014-07-04 | Galapagos (Belgium) | €1.9 million | warrant exercises | Galapagos\' employee | Capital increase | |
| 2014-07-03 | TxCell (France) Gene and Cell therapy Unit, Nice (UTCG) (France) Biosafe (Switzerland) | € 417,000 | grant | Conseil Régional Provence-Alpes-Côte-D’azur (France) | Autoimmune diseases - Inflammatory diseases | Grant |
| 2014-07-03 | Oasmia Pharmaceutical (Sweden) | SEK 50 million (€5.46 million) | private placement | international institutional investors and qualified investors in Sweden | Cancer - Oncology | Private placement |
